| Literature DB >> 34206268 |
Norhan K Abd El-Aziz1, Ahmed M Ammar1, Hend M El Damaty2, Rehab A Abd Elkader3, Hosam A Saad4, Waleed El-Kazzaz5, Eman Khalifa6.
Abstract
Mastitis remains a serious problem for dairy animals. The misappropriation of antimicrobial aEntities:
Keywords: RFLP–PCR; Streptococcus uberis; antimicrobial resistance; biocides; dairy cows; intramammary infections; virulence
Year: 2021 PMID: 34206268 PMCID: PMC8300258 DOI: 10.3390/ani11071849
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 2.752
Antimicrobial resistance of S. uberis isolated from lactating cows with clinical mastitis.
| Antimicrobial Class | AMA | No. of Resistant Isolates (%) | MAR Index | Fisher Exact |
|---|---|---|---|---|
| Beta-lactams | CX | 69 (100.00) | 0.048 | NE |
| AMP | 62 (89.85) | 0.043 | 0.007 | |
| AX | 48 (69.57) | 0.033 | <0.001 | |
| P | 55 (79.71) | 0.038 | <0.001 | |
| Beta-lactamase inhibitor | AMC | 24 (34.78) | 0.017 | <0.001 |
| Cephalosporins | CRO | 69 (100.00) | 0.048 | NE |
| CFP | 18 (26.09) | 0.012 | <0.001 | |
| CL | 69 (100.00) | 0.048 | NE | |
| FEP | 69 (100.00) | 0.048 | NE | |
| Non-beta Lactams (Carbapenems) | IPM | 0 (00.00) | 0.00 | <0.001 |
| Lincomycins | DA | 69 (100.00) | 0.048 | NE |
| Fluoroquinlones | CIP | 15 (21.74) | 0.010 | <0.001 |
| Tetracyclines | TE | 45 (65.22) | 0.031 | <0.001 |
| Macrolides | E | 51(73.91) | 0.035 | 0.001 |
| Aminoglycosides | S | 60 (86.96) | 0.041 | 0.002 |
| GEN | 14 (20.28) | 0.009 | <0.001 | |
| NEO | 28 (40.57) | 0.019 | <0.001 | |
| K | 21 (30.43) | 0.014 | <0.001 | |
| Phenicols | C | 38 (55.07) | 0.026 | <0.001 |
| Aminocoumarins | NV | 69 (100.00) | 0.048 | NE |
| Sulfonamides | SXT | 33 (47.83) | 0.023 | <0.001 |
MAR, multiple antibiotic resistance index; AX, amoxicillin; AMC, amoxicillin–clavulanic acid; CX, cloxacillin; CRO, ceftriaxone; CFP, cefoperazone; CL, cephalexin; FEP, cefepime; IPM, imipenem; S, streptomycin; DA, clindamycin; CIP, ciprofloxacin; TE, tetracycline; E, erythromycin; NEO, neomycin; P, penicillin; NV, novobiocin; AMP, ampicillin; GEN, gentamycin; C, chloramphenicol; K, kanamycin; SXT, trimethoprim–sulfamethoxazole; NE, not estimated. * p-value < 0.01 was considered highly statistically significant.
Figure 1Overall occurrence and clustering of S. uberis isolates (n = 69) in the investigated farms, their virulence attributes, and antimicrobial and biocide resistance patterns. The heatmap shows the occurrence of features in all isolates. The dendrogram indicates the hierarchical clustering of features and isolates. Different farms and feature categories are color-coded, as shown in the label. GEN, gentamycin; CFP, cefoperazone; K, kanamycin; NEO, neomycin; SXT, trimethoprim-sulfamethoxazole; CIP, ciprofloxacin; AMC, amoxicillin–clavulanic acid; C, chloramphenicol; AMP, ampicillin; P, penicillin; E, erythromycin; S, streptomycin; AX, amoxicillin; TE, tetracycline.
Virulence traits and antimicrobial and biocide resistance profiles of S. uberis (n = 69) isolated from dairy cows of different hygiene interventions.
| Isolate No. | Herd | Virulence | Antimicrobial Resistance Profile | Biocide Resistance Genes | |
|---|---|---|---|---|---|
| Phenotype | Resistance Genes | ||||
| 1 | A | ND | CX, CRO, CL, FEP, S, DA, TE, E, SXT, AMP, NV | ND | |
| 2 | AX, CX, CRO, CL, FEP, S, DA, TE, E, SXT, AMP, NV, C |
| |||
| 3 | AX, CX, CRO, CL, FEP, DA, TE, E, SXT, NV | ND | |||
| 4 | AX, AMC, CX, CRO, CL, FEP, S, DA, TE, E, SXT, P, AMP, NV, K, C | ||||
| 5 |
| AX, AMC, CX, CRO, CL, FEP, S, DA, E, P, AMP, NV | ND | ||
| 6 |
| CX, CRO, CL, FEP, S, DA, TE, NV | ND | ||
| 7 |
| AX, CX, CRO, CL, FEP, S, DA, CIP, TE, SXT, P, AMP, NV, NEO | ND | ||
| 8 | B | ND | AX, AMC, CX, CRO, CL, FEP, S, DA, TE, E, SXT, AMP, NV | ND | |
| 9 |
| AX, CX, CRO, CL, FEP, S, DA, SXT, P, NV |
| ||
| 10 | AX, AMC, CX, CRO, CL, FEP, S, DA, TE, AMP, NV, K | ND | |||
| 11 |
| AX, CX, CRO, CL, FEP, S, DA, SXT, AMP, NV, C |
| ||
| 12 | CX, CRO, CL, FEP, S, DA, E, NV, NEO | ND | |||
| 13 | CX, CRO, CFP, CL, FEP, S, DA, E, AMP, NV, K, C |
| |||
| 14 | CX, CRO, CL, FEP, DA, E, AMP, NV, NEO, C | ||||
| 15 |
| AX, CX, CRO, CL, FEP, S, DA, TE, E, SXT, AMP, NV |
| ||
| 16 |
| AMC, CX, CRO, CL, FEP, S, DA, TE, SXT, P, AMP, NV, K | ND | ||
| 17 | C | ND | CX, CRO, CFP, CL, FEP, S, DA, TE, E, SXT, P, AMP, NV, NEO | ||
| 18 | ND | AX, CX, CRO, CL, FEP, S, DA, E, SXT, P, AMP, NV, C | |||
| 19 |
| CX, CRO, CL, FEP, DA, E, P, AMP, NV, C |
| ||
| 20 |
| AX, CX, CRO, CL, FEP, S, DA, CIP, E, P, AMP, NV, K | |||
| 21 |
| AX, AMC, CX, CRO, CL, FEP, S, DA, TE, E, SXT, P, AMP, NV, C |
| ||
| 22 |
| AX, CX, CRO, CL, FEP, S, DA, E, AMP, NV, NEO, C | |||
| 23 |
| AX, CX, CRO, CL, FEP, S, DA, AMP, NV, C | ND | ||
| 24 |
| AX, CX, CRO, CL, FEP, S, DA, TE, E, P, AMP, NV, C |
| ||
| 25 |
| AX, CX, CRO, CFP, CL, FEP, S, DA, TE, E, SXT, NV, NEO, C | |||
| 26 | CX, CRO, CL, FEP, S, DA, E, SXT, P, AMP, NV, NEO, K, C | ||||
| 27 | AX, AMC, CX, CRO, CL, FEP, S, DA, TE, E, P, AMP, NV, C |
| |||
| 28 | AX, CX, CRO, CFP, CL, FEP, S, DA, TE, E, SXT, P, AMP, NV, K, C | ||||
| 29 |
| CX, CRO, CL, FEP, DA, E, P, AMP, NV, GEN, C | |||
| 30 |
| AX, CX, CRO, CL, FEP, S, DA, TE, AMP, NV, K, C | |||
| 31 |
| AX, AMC, CX, CRO, CL, FEP, S, DA, TE, E, P, AMP, NV, C | |||
| 32 | AX, CX, CRO, CL, FEP, S, DA, TE, E, P, AMP, NV, K, C | ||||
| 33 |
| AX, CX, CRO, CFP, CL, FEP, S, DA, TE, E, SXT, P, NV, GEN, NEO, K, C | |||
| 34 |
| AMC, CX, CRO, CFP, CL, FEP, S, DA, P, AMP, NV, C |
|
| |
| 35 |
| AX, CX, CRO, CL, FEP, S, DA, TE, SXT, P, AMP, NV, NEO, C | |||
| 36 | AMC, CX, CRO, CFP, CL, FEP, S, DA, TE, E, P, AMP, NV, GEN | ||||
| 37 |
| AX, CX, CRO, CFP, CL, FEP, S, DA, TE, E, P, AMP, NV | |||
| 38 |
| AX, AMC, CX, CRO, CFP, CL, FEP, S, DA, TE, E, P, AMP, NV, NEO, C | |||
| 39 |
| CX, CRO, CL, FEP, DA, P, AMP, NV | |||
| 40 | AX, AMC, CX, CRO, CL, FEP, S, DA, CIP, TE, E, SXT, P, AMP, NV | ||||
| 41 |
| AX, CX, CRO, CL, FEP, S, DA, TE, P, AMP, NV, GEN, NEO | |||
| 42 | D | ND | AX, CX, CRO, CL, FEP, S, DA, TE, E, P, AMP, NV, NEO | ||
| 43 | ND | AX, CX, CRO, CL, FEP, DA, CIP, SXT, P, AMP, NV, GEN, NEO | |||
| 44 | ND | AMC, CX, CRO, CFP, CL, FEP, S, DA, CIP, TE, E, SXT, P, AMP, NV, NEO | |||
| 45 | ND | AX, AMC, CX, CRO, CFP, CL, FEP, S, DA, CIP, TE, E, SXT, P, AMP, NV, K | |||
| 46 | ND | AX, AMC, CX, CRO, CFP, CL, FEP, S, DA, TE, E, P, AMP, NV, GEN, K | |||
| 47 | ND | CX, CRO, CL, FEP, S, DA, CIP, TE, E, SXT, P, AMP, NV, K | |||
| 48 | ND | AX, CX, CRO, CL, FEP, S, DA, TE, E, SXT, P, AMP, NV, NEO | |||
| 49 |
| AX, CX, CRO, CL, FEP, DA, CIP, TE, E, SXT, P, AMP, NV | |||
| 50 | AX, AMC, CX, CRO, CL, FEP, S, DA, TE, E, SXT, P, AMP, NV, GEN, NEO | ||||
| 51 |
| AX, AMC, CX, CRO, CL, FEP, S, DA, CIP, E, P, AMP, NV, NEO | |||
| 52 |
| CX, CRO, CL, FEP, S, DA, TE, E, P, AMP, NV, NEO | |||
| 53 |
| AX, CX, CRO, CL, FEP, S, DA, CIP, TE, SXT, P, AMP, NV, NEO | |||
| 54 |
| AX, AMC, CX, CRO, CL, FEP, S, DA, CIP, TE, E, SXT, P, AMP, NV | |||
| 55 | AX, CX, CRO, CFP, CL, FEP, S, DA, SXT, P, AMP, NV, C | ||||
| 56 |
| AX, AMC, CX, CRO, CFP, CL, FEP, S, DA, CIP, TE, E, P, AMP, NV, GEN, C | |||
| 57 | AX, AMC, CX, CRO, CFP, CL, FEP, S, DA, CIP, SXT, P, AMP, NV, GEN, NEO, C | ||||
| 58 | AMC, CX, CRO, CFP, CL, FEP, S, DA, CIP, TE, E, P, AMP, NV, GEN, NEO, C | ||||
| 59 | CX, CRO, CFP, CL, FEP, S, DA, TE, E, P, AMP, NV, C | ||||
| 60 | CX, CRO, CL, FEP, DA, TE, E, P, AMP, NV, K, C | ||||
| 61 | AX, CX, CRO, CL, FEP, S, DA, TE, E, SXT, P, AMP, NV, GEN, NEO, K, C | ||||
| 62 |
| AX, AMC, CX, CRO, CL, FEP, S, DA, TE, SXT, P, AMP, NV, NEO, K, C | |||
| 63 |
| CX, CRO, CFP, CL, FEP, S, DA, TE, E, SXT, P, AMP, NV, NEO, K, C | |||
| 64 |
| AX, CX, CRO, CL, FEP, S, DA, E, P, AMP, NV, NEO, C | |||
| 65 |
| CX, CRO, CL, FEP, DA, E, P, AMP, NV, C | |||
| 66 |
| AX, CX, CRO, CL, FEP, S, DA, CIP, E, P, AMP, NV, C | |||
| 67 |
| AX, AMC, CX, CRO, CL, FEP, S, DA, TE, E, P, AMP, NV, GEN, NEO, K, C | |||
| 68 |
| AX, CX, CRO, CL, FEP, S, DA, E, P, AMP, NV, GEN, NEO, K, C | |||
| 69 |
| AX, CX, CRO, CL, FEP, S, DA, P, AMP, NV, GEN, NEO, K, C | |||
AX, amoxicillin; AMC, amoxicillin–clavulanic acid; CX, cloxacillin; CRO, ceftriaxone; CFP, cefoperazone; CL, cephalexin; FEP, cefepime; IPM, imipenem; DA, clindamycin; CIP, ciprofloxacin; TE, tetracycline; E, erythromycin; NEO, neomycin; P, penicillin; NV, novobiocin; AMP, ampicillin; S, streptomycin; GEN, gentamycin; C, chloramphenicol; K, kanamycin; SXT, trimethoprim-sulfamethoxazole; ND, not detected.
Virulence gene profiles of S. uberis isolated from lactating cattle experience clinical mastitis.
| Molecular Pathotype | Virulence Genes | No. of | Farms |
|---|---|---|---|
| I | 8 (11.59) | C, D | |
| II | 3 (4.35) | A | |
| III | 4 (5.8) | B | |
| IV | 3 (4.35) | C | |
| V | 2 (2.9) | D | |
| VI |
| 15 (21.74) | A, C, D |
| VII |
| 10 (14.49) | A, B, C, D |
| VIII |
| 3 (4.35) | B, D |
| IX |
| 4 (5.8) | C, D |
| X |
| 3 (4.35) | C, D |
Figure 2Correlations among various features in S. uberis isolates (n = 69) from various farms. The color scale represents the correlation coefficient (R) on a scale from +1 to −1 (+1 is the highest positive correlation, and −1 is the highest negative correlation). AX, amoxicillin; AMC, amoxicillin–clavulanic acid; CFP, cefoperazone; S, streptomycin; CIP, ciprofloxacin; TE, tetracycline; E, erythromycin; SXT, trimethoprim-sulfamethoxazole; P, penicillin; AMP, ampicillin; GEN, gentamycin; NEO, neomycin; K, kanamycin; C, chloramphenicol.
Figure 3Differences among farms are shown in the term of studied features. Each horizontal bar represents the overall number of isolates (x-axis) showing a certain feature (including redundancy). Farms are shown in different colors. Farm D possessed the highest number of isolates harboring the studied features compared to other farms.
Figure 4A heatmap showed the binary distances among S. uberis isolates based on the presence or absence of the four studied features (Scheme 0.7).
Figure 5Hierarchical clustering dendrogram showing the relatedness (closeness) of various isolates (shown as numbers) from different farms (shown as colored dots) based on all the feature categories. All isolates were classified into four clusters.